Difference between revisions of "Pathology for medical students"

From Libre Pathology
Jump to navigation Jump to search
Line 64: Line 64:
**Receptors in breast cancer (ER, PR, HER2).
**Receptors in breast cancer (ER, PR, HER2).
**Lung cancer biomarkers ([[Lung_carcinoma_with_EGFR_mutation|EGFR]], [[Lung carcinoma with ALK rearrangement|ALK]], PD-L1, [[ROS1-rearranged non-small cell lung carcinoma|ROS1]]).
**Lung cancer biomarkers ([[Lung_carcinoma_with_EGFR_mutation|EGFR]], [[Lung carcinoma with ALK rearrangement|ALK]], PD-L1, [[ROS1-rearranged non-small cell lung carcinoma|ROS1]]).
**BRAF testing in malignant melanoma.
**BRAF testing in [[malignant melanoma]].
**[[Microsatellite instability in colorectal cancer|MSI testing]] in colorectal cancer.
**[[Microsatellite instability in colorectal cancer|MSI testing]] in [[colorectal cancer]].


==See also==
==See also==

Revision as of 19:44, 7 June 2020

This article is an introduction to pathology for medical students.

Compentencies

Describing injuries

Pre-autopsy

Autopsy

  • Identifying medical examiner cases/coroner's cases.
  • Getting an autopsy consent.
    • Understanding the hierarchy and knowing it must be followed strictly.
    • Knowing the difference between executer of the estate and power of attorney for health care decisions (not valid after death).
  • Providing important clinical information.
    • Clinical history - past medical history.
    • Events leading-up to death.
    • Provisional/suspected cause of death.
  • Value of doing an autopsy.
  • Interpretation of autopsy reports.

Surgical pathology

  • Ordering biopsies and laboratory tests.
    • Infectious cases - role of culture.
  • Interpreting pathology reports.
  • Importance of providing clinical information.
    • Consultant for a specialist should have a reason for referral - pathology is not different.

Cancer diagnoses

Definitions:

  • Cancer.
    • Pathologic definitions of cancer.
  • Tumour.
    • Not necessarily cancer.
    • Locally aggressive tumours, e.g. desmoid tumour.
    • Benign tumours.

Pitfalls:

Implication of not otherwise specified:

Prognostic factors:

Techniques

See also